Gait Rehabilitation System Market: Segmented By Product (Mechanical Type, Computer-aided and Others); By End-User (Hospital, Clinic, Rehabilitation Center and Other) Global Analysis By Market Size, Share & Trends For 2020-2021 And Forecasts To 2031
[ 176 + Pages Research Report ] Gait Rehabilitation System Market to surpass USD 225.8 billion by 2031 from USD 136.8 billion in 2021 at a CAGR of 5.14% within the coming years, i.e., 2021-31.
Product overview
Gait rehabilitation technology is rising exponentially as retrieval functional gait is seen as a must for independent living in real-world situations. The several kinds of walking difficulties have urged the growth of the broad spectrum of gait systems in many neurological, medical, and traumatic diseases. Gait Rehabilitation system is a significant part of the therapy plan for patients with movement disorders of the lower extremities. The goal of rehabilitation system is mainly helping the patient return to the highest possible level of function and independence while improving the overall quality of life - physically, emotionally, and socially.
Market Highlights
Gait Rehabilitation System Market is predicted to project a notable CAGR of 5.14% in 2031.
Components such as the growing incidence of neurological disorders, and rising number of sports injuries and orthopedic diseases cases drive the market growth.
Gait Rehabilitation System Market: Segments
Mechanical segment to grow with the highest CAGR during 2021-2031
On the basis of Product, Gait Rehabilitation System Market is segmented into Mechanical Type, Computer-aided, and Others. Mechanical type segment held a maximum market share and is anticipated to register a higher CAGR during the forecast years.
Hospital segment to grow with the highest CAGR during 2021-2031
Based on End-user, Gait Rehabilitation System Market is broadly segmented into hospitals, clinics, Rehabilitation Center, and Others. Hospital segment accounted for the largest share in the Gait Rehabilitation System Market. Whereas the market for the rehabilitation centers segment is expected to grow at a CAGR of 6.3% during the forecast years.
Gait Rehabilitation System Market: Market Dynamics
Drivers
Increasing number of stroke and neurological disorders resulting
Factors driving the growth of the gait rehabilitation system market are the increasing number of stroke and neurological disorders which results in gait disabilities worldwide, along with Technological advancement in the gait rehabilitation systems. Additionally, increasing uses of gait rehabilitation system in nutraceutical industries and growing investments by major market players in capsule manufacturing plants is expected to drive the market growth.
Increasing spending on healthcare
The increasing spending on healthcare in developing economies is enabling companies to operate in this sector to offer a large range of superior-quality offerings. Therefore, the adoption of gait rehabilitation systems is likely to increase in regions such as Asia, the Middle East, and Africa in the forecast years.
Restraints
Huge capital investment and high cost
Gait Rehabilitation System needs high capital investment and integration of complex mechanisms, which are the major challenges during the early phase. The high cost of vegetarian gait rehabilitation system is expected to hinder the growth of Gait Rehabilitation System Market.
Effects of COVID19 in the Gait Rehabilitation System Market
Gait rehabilitation systems market suffered a shortage at the start of the COVID-19 crisis owing to supply chain disruption and demand due to the lockdown announced by most countries. COVID-19 has had a significant negative effect on the gait rehabilitation systems market. The COVID-19 pandemic can deprive patients with neurological diseases of their usual care. During the COVID-19 pandemic, there was a tendency of home exercise plans owing to the limited period of therapy and access to physical treatment. Self-rehabilitation at home is a progressively common part of rehabilitation programs, especially for various long-term illnesses such as MS.
Gait Rehabilitation System Market: Key Players
Lonza
Company Overview, Business Strategy, Key Product Offerings, financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Pacific BioLabs
Charles River
Merck
Eurofins
Medicilon
GenScript
BioM?rieux/Hyglos
Accugen Labs
Fujifilm
Steris
Nelson Laboratories
Other prominent players
Gait Rehabilitation System Market: Regions
Gait Rehabilitation System Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. North America is expected to witness the maximum market growth. The development of the market can be because of the growing burden of strokes among geriatric population, growing product launches, and R&D Activities as well as other activities undertaken by the prominent market players operating in the market so as to develop advanced gait rehabilitation systems. On the other hand, Asia Pacific is also expected to register growth in the forecast timeframe.
Gait Rehabilitation System Market is further segmented by region into:
North America Market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR-United States and Canada
Latin America Market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR-Mexico, Argentina, Brazil, and Rest of Latin America
Europe market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR- United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market size, Share Trends, Opportunities, Y-o-Y Growth, CAGR-India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
Middle East and Africa Market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Gait Rehabilitation System Market report also contains analysis on:
Gait Rehabilitation System Market Segments:
By Product
Mechanical Type
Computer-aided
Others
By End-User
Hospital
Clinic
Rehabilitation Center
Other
Gait Rehabilitation System Market Dynamics
Gait Rehabilitation System Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value chain of the Market
Market Drivers and Restraints
Gait Rehabilitation System Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 136.8 billion
Revenue forecast in 2031 USD 225.8 billion
Growth Rate CAGR of 5.14% from 2021 to 2031
Base year for estimation 2021
Quantitative units Revenue in USD billion and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, End-user, and Region
Region scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Lonza, Pacific BioLabs, Charles River, Merck, Eurofins, Medicilon, GenScript, BioM?rieux/Hyglos, Accugen Labs, Fujifilm, Steris, Nelson Laboratories
Product overview
Gait rehabilitation technology is rising exponentially as retrieval functional gait is seen as a must for independent living in real-world situations. The several kinds of walking difficulties have urged the growth of the broad spectrum of gait systems in many neurological, medical, and traumatic diseases. Gait Rehabilitation system is a significant part of the therapy plan for patients with movement disorders of the lower extremities. The goal of rehabilitation system is mainly helping the patient return to the highest possible level of function and independence while improving the overall quality of life - physically, emotionally, and socially.
Market Highlights
Gait Rehabilitation System Market is predicted to project a notable CAGR of 5.14% in 2031.
Components such as the growing incidence of neurological disorders, and rising number of sports injuries and orthopedic diseases cases drive the market growth.
Gait Rehabilitation System Market: Segments
Mechanical segment to grow with the highest CAGR during 2021-2031
On the basis of Product, Gait Rehabilitation System Market is segmented into Mechanical Type, Computer-aided, and Others. Mechanical type segment held a maximum market share and is anticipated to register a higher CAGR during the forecast years.
Hospital segment to grow with the highest CAGR during 2021-2031
Based on End-user, Gait Rehabilitation System Market is broadly segmented into hospitals, clinics, Rehabilitation Center, and Others. Hospital segment accounted for the largest share in the Gait Rehabilitation System Market. Whereas the market for the rehabilitation centers segment is expected to grow at a CAGR of 6.3% during the forecast years.
Gait Rehabilitation System Market: Market Dynamics
Drivers
Increasing number of stroke and neurological disorders resulting
Factors driving the growth of the gait rehabilitation system market are the increasing number of stroke and neurological disorders which results in gait disabilities worldwide, along with Technological advancement in the gait rehabilitation systems. Additionally, increasing uses of gait rehabilitation system in nutraceutical industries and growing investments by major market players in capsule manufacturing plants is expected to drive the market growth.
Increasing spending on healthcare
The increasing spending on healthcare in developing economies is enabling companies to operate in this sector to offer a large range of superior-quality offerings. Therefore, the adoption of gait rehabilitation systems is likely to increase in regions such as Asia, the Middle East, and Africa in the forecast years.
Restraints
Huge capital investment and high cost
Gait Rehabilitation System needs high capital investment and integration of complex mechanisms, which are the major challenges during the early phase. The high cost of vegetarian gait rehabilitation system is expected to hinder the growth of Gait Rehabilitation System Market.
Effects of COVID19 in the Gait Rehabilitation System Market
Gait rehabilitation systems market suffered a shortage at the start of the COVID-19 crisis owing to supply chain disruption and demand due to the lockdown announced by most countries. COVID-19 has had a significant negative effect on the gait rehabilitation systems market. The COVID-19 pandemic can deprive patients with neurological diseases of their usual care. During the COVID-19 pandemic, there was a tendency of home exercise plans owing to the limited period of therapy and access to physical treatment. Self-rehabilitation at home is a progressively common part of rehabilitation programs, especially for various long-term illnesses such as MS.
Gait Rehabilitation System Market: Key Players
Lonza
Company Overview, Business Strategy, Key Product Offerings, financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Pacific BioLabs
Charles River
Merck
Eurofins
Medicilon
GenScript
BioM?rieux/Hyglos
Accugen Labs
Fujifilm
Steris
Nelson Laboratories
Other prominent players
Gait Rehabilitation System Market: Regions
Gait Rehabilitation System Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. North America is expected to witness the maximum market growth. The development of the market can be because of the growing burden of strokes among geriatric population, growing product launches, and R&D Activities as well as other activities undertaken by the prominent market players operating in the market so as to develop advanced gait rehabilitation systems. On the other hand, Asia Pacific is also expected to register growth in the forecast timeframe.
Gait Rehabilitation System Market is further segmented by region into:
North America Market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR-United States and Canada
Latin America Market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR-Mexico, Argentina, Brazil, and Rest of Latin America
Europe market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR- United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market size, Share Trends, Opportunities, Y-o-Y Growth, CAGR-India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
Middle East and Africa Market Size, Share Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Gait Rehabilitation System Market report also contains analysis on:
Gait Rehabilitation System Market Segments:
By Product
Mechanical Type
Computer-aided
Others
By End-User
Hospital
Clinic
Rehabilitation Center
Other
Gait Rehabilitation System Market Dynamics
Gait Rehabilitation System Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value chain of the Market
Market Drivers and Restraints
Gait Rehabilitation System Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 136.8 billion
Revenue forecast in 2031 USD 225.8 billion
Growth Rate CAGR of 5.14% from 2021 to 2031
Base year for estimation 2021
Quantitative units Revenue in USD billion and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product, End-user, and Region
Region scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
Key companies profiled Lonza, Pacific BioLabs, Charles River, Merck, Eurofins, Medicilon, GenScript, BioM?rieux/Hyglos, Accugen Labs, Fujifilm, Steris, Nelson Laboratories
1. EXECUTIVE SUMMARY
2. GAIT REHABILITATION SYSTEM MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GAIT REHABILITATION SYSTEM MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GAIT REHABILITATION SYSTEM MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GAIT REHABILITATION SYSTEM: MARKET SEGMENTATION
12.1. By Regions: Market Share (2020-2030F)
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Mechanical Type, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Computer-aided, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End-User Industry: Market Share (2020-2030F)
12.3.1. Hospital, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Clinic, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
1. LONZA
1. COMPANY OVERVIEW
2. COMPANY TOTAL REVENUE (FINANCIALS)
3. MARKET POTENTIAL
4. GLOBAL PRESENCE
5. KEY PERFORMANCE INDICATORS
6. SWOT ANALYSIS
7. PRODUCT LAUNCH
2. PACIFIC BIOLABS
3. CHARLES RIVER
4. MERCK
5. EUROFINS
6. MEDICILON
7. GENSCRIPT
8. BIOM?RIEUX/HYGLOS
9. ACCUGEN LABS
10. FUJIFILM
11. STERIS
12. NELSON LABORATORIES
13. OTHER PROMINENT PLAYERS
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GAIT REHABILITATION SYSTEM MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GAIT REHABILITATION SYSTEM MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GAIT REHABILITATION SYSTEM MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GAIT REHABILITATION SYSTEM: MARKET SEGMENTATION
12.1. By Regions: Market Share (2020-2030F)
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Mechanical Type, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Computer-aided, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End-User Industry: Market Share (2020-2030F)
12.3.1. Hospital, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Clinic, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
1. LONZA
1. COMPANY OVERVIEW
2. COMPANY TOTAL REVENUE (FINANCIALS)
3. MARKET POTENTIAL
4. GLOBAL PRESENCE
5. KEY PERFORMANCE INDICATORS
6. SWOT ANALYSIS
7. PRODUCT LAUNCH
2. PACIFIC BIOLABS
3. CHARLES RIVER
4. MERCK
5. EUROFINS
6. MEDICILON
7. GENSCRIPT
8. BIOM?RIEUX/HYGLOS
9. ACCUGEN LABS
10. FUJIFILM
11. STERIS
12. NELSON LABORATORIES
13. OTHER PROMINENT PLAYERS
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
